Zoledronic Acid Sensitizes Renal Cell Carcinoma Cells to Radiation by Downregulating STAT1

Zoledronic acid (ZOL), a third-generation bisphosphonate that strongly inhibits osteoclast activity, is widely used for the treatment of bone metastasis from a variety of malignancies, including renal cell carcinoma (RCC). We previously reported that zoledronic acid (ZOL) clinically potentiates anti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kijima, Toshiki, Koga, Fumitaka, Fujii, Yasuhisa, Yoshida, Soichiro, Tatokoro, Manabu, Kihara, Kazunori
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2013
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3669422/
https://ncbi.nlm.nih.gov/pubmed/23741352
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0064615
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados